Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Notable Health›
Analysis
AddedFeb 15, 2024
UpdatedMay 31, 2026
Notable Health

Notable Health

Series B

Notable Health: A health tech firm enhancing patient-physician interactions via intelligent automation.

HQ
San Mateo, CA, US
Founded
2017
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths

Product Overview

Notable Health is the leading intelligent automation platform purpose-built for healthcare. The company's AI platform processes over 1.5 million tasks per day, automating patient engagement and staff workflows for health systems and large practices.

Notable's technology streamlines administrative tasks, reduces healthcare costs, and improves patient engagement through modern digital solutions that leverage AI and intelligent automation.

Market Outlook

The healthcare AI market is projected to grow from $39B in 2025 to $504B by 2032, reflecting massive expansion driven by the convergence of AI capabilities and healthcare administrative inefficiencies. The healthcare RPA subsegment specifically is forecast to grow from $2.8B in 2025 to $22.56B by 2034 at a 26.1% CAGR, representing one of the fastest-growing vertical applications of automation technology. U.S. healthcare spends an estimated $1.1 trillion annually on administration, with 8x more resources per $1B revenue than any other industry, creating enormous addressable market for intelligent automation. Several structural tailwinds are accelerating adoption: nursing and clinical workforce shortages driving $90B/year in supplemental labor costs, COVID-19 permanently shifting patient expectations toward digital-first interactions, and regulatory pressure around value-based care requiring health systems to close care gaps and manage population health more effectively.

The market is evolving from simple rule-based RPA toward intelligent automation that combines cognitive AI (LLMs, NLP, document processing) with traditional RPA execution, which is exactly Notable's platform positioning. North America represents the largest market at 36.24% of global revenue, with major health systems actively deploying AI automation across revenue cycle, clinical documentation, and patient engagement. Key risks include high upfront implementation costs (exceeding $1M for midsize hospitals), cybersecurity threats (healthcare suffers 25% more incidents than other industries), legacy infrastructure complexity, and staff change management resistance. Notable's HITRUST AI Security certification and SOC 2 Type 2 compliance directly address the security and trust concerns that slow enterprise adoption.

Competitive Advantages

Notable's primary competitive advantage is its position as the first platform to combine AI Agents (agentic AI with NLP, LLMs, document processing, and voice capabilities) with robotic process automation (RPA) in a healthcare-specific product, which the company calls intelligent automation. Unlike horizontal RPA platforms such as UiPath, Notable embeds deep healthcare domain knowledge including EHR data models, clinical workflows, and payer processes. Its RPA layer automates through the graphical user interface rather than relying solely on APIs, which is critical in healthcare where many EHR capabilities lack API access. This approach enables Notable to write data into EHR sticky notes and navigate clinical interfaces that API-only solutions cannot reach. The platform spans the full care continuum: patient access, revenue cycle management, care operations, and contact center, positioning it as an end-to-end solution rather than a point product.

Proven ROI metrics reinforce the advantage: MUSC Health reports $3.3M annual value, Montage Health achieved an 83% reduction in referral turnaround time (21 days to 3.6 days), and Catholic Health projects $350K+ annual savings with a 57% voice AI containment rate. Notable is also among the first healthcare AI platforms to earn the HITRUST AI Security (ai2) Certification (December 2025), addressing AI-specific threats like data poisoning, model inversion, and prompt injection. The company's Flow Builder provides a low-code design interface enabling customers to create custom automations without engineering resources, and Flow AI allows conversational workflow creation, lowering deployment barriers.